We transform Australia & New Zealand's most exciting biomedical research discoveries into new medical products that improve patient outcomes and save lives.

Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.

Learn more about who we are
CUREator is an Australian national biotechnology incubator supporting the development of pre-clinical and clinical stage medical innovation.

Portfolio

We’re immensely proud of our portfolio. Partnering with talented scientists, clinicians and entrepreneurs, we have supported more than 50 companies to date.

Vaxxas
Vaxxas

Vaxxas' proprietary Nanopatch™ technology is a needle-free vaccine delivery solution

View Project
CatalYm
CatalYm

Reversing GDF-15-mediated immunosupression to induce anti-tumour responses

View Project
Entact Bio
Entact Bio

Developing a new class of therapeutics that enhance the function of beneficial proteins

View Project
Developing disease-modifying mitochondrial therapeutics for neurodegenerative disorders
Developing disease-modifying mitochondrial therapeutics for neurodegenerative disorders

View Project
Pheon Therapeutics
Pheon Therapeutics

Developing first-in-class ADCs to treat cancer

View Project
TamoRx
TamoRx

Developing novel immuno-oncology small molecule inhibitors

View Project
Amaroq Therapeutics
Amaroq Therapeutics

Targeting long non-coding RNAs for next generation cancer therapies

View Project
Currus Biologics
Currus Biologics

Developing the next generation of CAR-T cell therapies to treat solid cancers

View Project
See all

Members

Brandon BioCatalyst brings together more than 50 leading medical research institutes across Australia and New Zealand.

Institute
The Curtin Health Innovation Research Institute (CHIRI)

The Curtin Health Innovation Research Institute (CHIRI) is dedicated to developing new treatments for diseases that more commonly occur with older age.

View
Institute
Institute for Molecular Bioscience

IMB is a global leader in multidisciplinary life sciences research, bringing together 500 researchers from across the globe for disease discovery, application and sustainable futures. Formed in 2000 as an initiative of The University of Queensland, State and Federal Governments and private philanthropy, IMB is one of the largest life sciences institutes in the Asia-Pacific region. It has capitalised on one of the greatest periods of discovery in history – the genetic and molecular basis of life and its diversity.

View
Institute
The George Institute

The George Institute for Global Health is a not-for-profit global medical research institute established and headquartered in Sydney, with major centres in China, India and the UK, and an international network of experts and collaborators.

View

Membership

Brandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.

Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.

Learn more